Stock IVBT INNOVATION1 BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Innovation1 Biotech Inc.

Equities

IVBT

US39809D2018

Market Closed - OTC Markets
Other stock markets
 14:31:07 19/04/2024 BST 		5-day change 1st Jan Change
0.0008 USD -96.36% Intraday chart for Innovation1 Biotech Inc. -.--% -99.07%
01-17 Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 CI
2023 Innovation1 Biotech Inc. announced that it has received $0.15 million in funding CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Innovation1 Biotech : New Financial Obligation - Form 8-K
PU
Innovation1 Biotech : Material Agreement - Form 8-K
PU
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors
AQ
Innovation1 Biotech Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction
AQ
Innovation1 Biotech : Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors - Form 8-K
PU
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors
AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
INNOVATION1 BIOTECH INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
INNOVATION1 BIOTECH INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IVBT Stock
  4. News Innovation1 Biotech Inc.
  5. Press Releases